To date, no study has ever evaluated the association between circulating levels of ANGPTL8 and c-IMT or considered the possibility of identifying ANGPTL8 as a risk biomarker for subclinical atherosclerosis in type 2 diabetes. The gene discussed is ANGPTL8; the disease is type 2 diabetes mellitus.